Registration Dossier
Registration Dossier
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 216-323-7 | CAS number: 1559-35-9
Toxicological Summary
Administrative data
Workers - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 1.47 mg/m³
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 300
- Dose descriptor starting point:
- NOAEL
- Value:
- 1.47 mg/m³
- Value:
- 1.47 mg/m³
- Explanation for the modification of the dose descriptor starting point:
DNEL Derivation
The starting point for the DNEL derivation was from an OECD 422 28-day repeat dose/reproductive screen, where the NOAEL was 500 mg/kg/day, the highest dose tested.
The derivation of theWorker long-term systemic inhalation DNELwas as follows.
- NOAEL of 500 mg/kg/day. Correct to an inhalation dose with a factor of 0.38 m3/kg. 500/0.38 = 1315 mg/m3.
- The value is then corrected for 50% bioavailability by the oral route. 1315 mg/m3/2 = 657.89 mg/m3.
- The value is then corrected for increased respiration for light work. 657*0.67 = 440.79.
- This value is then dived by the adjustment factor of 300 for a final DNEL of 1.47. The adjustment factors are as follows:
Intraspecies: 5
Allometric scaling 4
Interspecies 2.5
Subacute to chronic 6
- AF for differences in duration of exposure:
- 6
- AF for interspecies differences (allometric scaling):
- 4
- AF for other interspecies differences:
- 2.5
- AF for intraspecies differences:
- 5
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Workers - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 1.67 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 300
- Dose descriptor starting point:
- NOAEL
- Value:
- 1.67 mg/kg bw/day
- Modified dose descriptor starting point:
- NOAEL
- Value:
- 1.67 mg/kg bw/day
- Explanation for the modification of the dose descriptor starting point:
DNEL Derivation
The derivation of theWorker long-term systemic Dermal DNELwas as follows.
- NOAEL of 500 mg/kg/day. Divide by a total adjustment factor of 300 for a DNEL of 1.67 mg/kg
- The adjustment factors are as follows:
Intraspecies: 5
Allometric scaling 4
Interspecies 2.5
Subacute to chronic 6
- AF for differences in duration of exposure:
- 6
- AF for interspecies differences (allometric scaling):
- 4
- AF for other interspecies differences:
- 2.5
- AF for intraspecies differences:
- 5
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
Workers - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- medium hazard (no threshold derived)
Additional information - workers
General Population - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 0.36 mg/m³
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 600
- Dose descriptor starting point:
- NOAEL
- Value:
- 0.36 mg/m³
- Value:
- 0.36 mg/m³
- Explanation for the modification of the dose descriptor starting point:
DNEL Derivation
The derivation of theGeneral Population long-term systemic inhalation DNELwas as follows.
- NOAEL of 500 mg/kg/day. Correct to an inhalation dose with a factor of 1.15 m3/kg. 500/1.15 = 474 mg/m3.
- The value is then corrected for 50% bioavailability by the oral route. 434 mg/m3/2 = 217 mg/m3.
- This value is then dived by the adjustment factor of 600 for a final DNEL of 0.36 The adjustment factors are as follows:
Intraspecies: 10
Allometric scaling 4
Interspecies 2.5
Subacute to chronic 6
- AF for differences in duration of exposure:
- 6
- AF for interspecies differences (allometric scaling):
- 4
- AF for other interspecies differences:
- 2.5
- AF for intraspecies differences:
- 10
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
General Population - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 0.83 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 600
- Dose descriptor starting point:
- NOAEL
- Value:
- 0.83 mg/kg bw/day
- Modified dose descriptor starting point:
- NOAEL
- Value:
- 0.83 mg/kg bw/day
- Explanation for the modification of the dose descriptor starting point:
DNEL Derivation
The derivation of theGeneral Population long-term systemic Oral/Dermal DNELwas as follows.
- NOAEL of 500 mg/kg/day.
- Divide by a total adjustment factor of 300 for a DNEL of 0.83 mg/kg
- The adjustment factors are as follows:
Intraspecies: 10
Allometric scaling 4
Interspecies 2.5
Subacute to chronic 6
- AF for differences in duration of exposure:
- 6
- AF for interspecies differences (allometric scaling):
- 4
- AF for other interspecies differences:
- 2.5
- AF for intraspecies differences:
- 10
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
General Population - Hazard via oral route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 0.83 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 600
- Dose descriptor starting point:
- NOAEL
- Value:
- 0.83 mg/kg bw/day
- Modified dose descriptor starting point:
- NOAEL
- Value:
- 0.83 mg/kg bw/day
- Explanation for the modification of the dose descriptor starting point:
DNEL Derivation
The derivation of theGeneral Population long-term systemic Oral/Dermal DNELwas as follows.
- NOAEL of 500 mg/kg/day.
- Divide by a total adjustment factor of 300 for a DNEL of 0.83 mg/kg
- The adjustment factors are as follows:
Intraspecies: 10
Allometric scaling 4
Interspecies 2.5
Subacute to chronic 6
- AF for differences in duration of exposure:
- 6
- AF for interspecies differences (allometric scaling):
- 4
- AF for other interspecies differences:
- 2.5
- AF for intraspecies differences:
- 10
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
General Population - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- medium hazard (no threshold derived)
Additional information - General Population
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
